Manganese for Bone Fracture
There is no reliable human evidence that manganese supplements prevent or heal bone fractures; the verdict reflects an evidence gap (Unverified), not proof of benefit, and high-dose manganese carries a genuine neurotoxicity risk.
Why this grade7-layer evidence engine
This claim is graded Unverified / Insufficient Evidence because the human evidence base for the fracture endpoint is essentially empty. PubMed contains no randomized trial of manganese alone with fractures as an outcome. The most-cited study, Strause 1994 (PMID 8027856, n=59), tested a calcium-plus-trace-mineral blend (zinc, manganese, copper), measured spinal bone mineral density rather than fractures, was industry-funded and underpowered, and cannot isolate any manganese-specific effect.
Supporting reviews reinforce the gap rather than fill it. A narrative review of manganese in human nutrition (PMID 8074260) notes that documented manganese deficiency in people is extremely rare and that no human trial has tested isolated manganese on fractures, while a 2023 review of trace elements in osteoporosis (PMID 37371586) explicitly cautions against extrapolating combination-formula benefits to single-mineral supplements. NHANES cross-sectional data (PMID 36269752, n=1,496) show only a non-linear, U-shaped serum-manganese-to-BMD association that cannot prove cause or justify supplementation.
Regulators and clinics treat manganese only as an essential nutrient, not a fracture therapy. The FDA lists it as a nutrient supplement with no approved health claim, and EFSA's generic 'maintenance of normal bones' wording sits alongside its 2023 decision to cut the adult tolerable upper intake to 3 mg/day over neurotoxicity concerns. The NHS and WHO are cautious, warning that high long-term doses can cause nerve damage (manganism). Clinical bodies (NIH ODS, Mayo, Harvard, orthopedic societies) do not endorse manganese for fractures, leaving no proven benefit set against a real safety ceiling.
Scoring transparency
All scores computed by a 7-layer evidence engine — fully auditable▸View the full decision path (audit trail)
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.448
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 無高階證據可裁決
- tier_strict_requirement_check — | C→U 因 scope.conflation_risk=true 且 L11 獨評較低 (B7-2 tier cap)
- detect_disputes — 偵測到 0 個 hard + 1 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status